Investors will know their Sudeep Pharma IPO allotment status on Wednesday. The offering saw strong demand. Grey market activity suggests a listing premium. Shares may list higher than the issue price. Refunds and demat credits are scheduled for November 27. The company is set to list on November 28 on NSE and BSE. A positive debut is expected.